The use of direct oral anticoagulants in inherited thrombophilia

@article{Skelley2016TheUO,
  title={The use of direct oral anticoagulants in inherited thrombophilia},
  author={Jessica W. Skelley and C. W. White and Angela R. Thomason},
  journal={Journal of Thrombosis and Thrombolysis},
  year={2016},
  volume={43},
  pages={24-30}
}
To review the use of the direct oral anticoagulant (DOAC) agents in inherited thrombophilia based on the literature. MEDLINE, International Pharmaceutical Abstracts, and Google Scholar searches (1970–May 2016) were conducted for case reports, case series, retrospective cohorts, or clinical trials using the key words: protein C deficiency, protein S deficiency, antithrombin deficiency, activated protein C resistance, Factor V Leiden, hypercoagulable, NOACs, dabigatran, apixaban, rivaroxaban… Expand
40 Citations
Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency
  • 4
  • PDF
Rivaroxaban in Recurrent Ischemic Stroke Due to Protein S Deficiency: A Case Report
  • PDF
Direct Oral Anticoagulants
Management of antithrombin deficiency: an update for clinicians
  • 4
...
1
2
3
4
...

References

SHOWING 1-10 OF 53 REFERENCES
Use of New Oral Anticoagulants in Antiphospholipid Syndrome
  • 57
...
1
2
3
4
5
...